Rakesh Jain, MD, MPH, RD

Quiz

What percentage of patients with TRD may have bipolar depression?

11/13/2024

Rakesh Jain , MD, MPH, RD;

Brooke Kempf , MSN, PMHNP-BC;

Time to test your knowledge with a pop quiz!

Time to test your knowledge with...

11/13/2024

Psych Congress NP Institute

Clinical Pearls

Using Comprehensive Management of TRD to Improve Patient Outcomes

11/05/2024

Brooke Kempf , MSN, PMHNP-BC;

Rakesh Jain , MD, MPH, RD;

Discover why careful diagnosis is crucial, how to leverage glutamatergic therapies, and the role of holistic methods like exercise and psychotherapy in improving patient outcomes.

Discover why careful diagnosis...

11/05/2024

Psych Congress NP Institute

A New Method for Initiating Treatment With the Long-acting Antipsychotic Aripiprazole Lauroxil

BACKGROUND: Significant delay can occur between the first dose of a long-acting injectable (LAI) antipsychotic and achievement of efficacious plasma concentrations, which is usually addre...

Lisa L. von Moltke , MD, FCPP;

Bhaskar Rege , PhD, BPharm;

Peter J. Weiden , MD, PhD;

Jonathan Meyer , MD;

Rakesh Jain , MD, MPH, RD;

Angela Wehr , PhD;

03/01/2019

TD360: Outcomes of a Tardive Dyskinesia Educational Curriculum – A Focus on Quality of Life, Increased Detection and Novel Treatments

TD360 Background

Paula Williams ;

Michelle Stewart ;

Chirag B. Shah , PharmD, MD;

Rakesh Jain , MD, MPH, RD;

11/01/2020

The Rapid Mood Screener: A Novel and Pragmatic Screener Tool for Bipolar I Disorder

Introduction: Depressive episodes/symptoms of bipolar I disorder (BPD-I) are commonly misdiagnosed as major depressive disorder (MDD). We developed the novel and pragmatic Rapid Mood Scre...

Patrick Gillard , PharmD, MS;

Amanda Harrington , PhD;

Kate Sullivan , APN, RN;

Lauren Nelson , PhD;

Roger McIntyre , MD, FRCPC;

Susan McElroy , MD;

Rakesh Jain , MD, MPH, RD;

Charles Brendan Montano , MD;

Mehul Patel , MD, PharmD;

T. Michelle Brown , PhD;

Prakash M. Masand , MD;

10/08/2020

Videos

Approaching Psychedelics for Depression With Both Caution and Optimism

02/06/2024

Rakesh Jain , MD, MPH, RD;

Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.

Rakesh Jain, MD, MPH, explains...

02/06/2024

Psych Congress Network

Impact of Lemborexant on Patient-Reported Insomnia-Related Worry/Distress and Interference With Daily Functioning Over 6 Months: Results From SUNRISE-2

INTRODUCTION: The insomnia severity index (ISI) is a self-report instrument that evaluates perception of insomnia severity. In Study 303 (SUNRISE-2), lemborexant (LEM) showed greater red...

Rakesh Jain , MD, MPH, RD;

Jane Yardley , PhD;

Kate Pinner , MSc;

Manoj Malhotra , MD;

Margaret Moline , PhD;

Norman Atkins Jr., MBA, PhD;

Craig Chepke , MD, DFAPA;

10/08/2020

Effect of Lemborexant Treatment Across 12 Months on Fatigue Severity and Sleep Outcomes in Subjects With Clinically Significant Fatigue at Baseline

Introduction: The Fatigue Severity Scale (FSS) assesses impact of fatigue on patients’ lives. Lemborexant (LEM) efficacy was examined in the subgroup of subjects with baseline FSS total s...

Norman Atkins Jr., MBA, PhD;

Craig Chepke , MD, DFAPA;

Rakesh Jain , MD, MPH, RD;

Jane Yardley , PhD;

Manoj Malhotra , MD;

Kate Pinner , MSc;

Margaret Moline , PhD;

10/08/2020

Efficacy of Cariprazine in Patient Subgroups: Post Hoc Analysis of 3 Randomized, Placebo-Controlled Trials in Patients With Bipolar Depression

Introduction: Cariprazine is a dopamine D3-preferring D3/D2 and serotonin 5-HT1A receptor partial agonist approved to treat bipolar depression. The efficacy of cariprazine in patients wit...

Vladimir Maletic , MD;

Lakshmi Yatham , MBBS, FRCPC, MRCP, MBA;

Rakesh Jain , MD, MPH, RD;

Willie Earley , MD;

Mehul Patel , MD, PharmD;

Mauricio Tohen , MD, DrPH, MBA;

10/08/2020

Bipolar Disorder Treatment Patterns in the United States: A Retrospective Claims Database Study

Background: The objective of this retrospective study was to describe treatment patterns among patients with bipolar disorder.

Mehul Patel , MD, PharmD;

Patrick Gillard , PharmD, MS;

Amanda Harrington , PhD;